VP, Inflammation & Immunology Clinical Development

Mygwork; Maryland; On-site; USD 300,000 - 520,000; Full time

Job summary

Gilead Sciences Inc. seeks a senior leader to define and execute clinical development strategies in inflammation and autoimmune diseases.

You will guide a multi-asset portfolio from pre-IND through late-stage development, ensuring scientific rigor, regulatory alignment, and strong external partnerships. You will lead matrixed teams, manage governance processes, and partner with internal and external stakeholders to deliver high-impact therapies.

Qualifications

• M.D. or M.D./Ph.D. required; 10+ years of relevant industry experience preferred.
• Significant pharmaceutical or biotechnology clinical development experience, including global program leadership and cross-functional governance experience.
• Deep expertise in inflammation, immunology, rheumatology, autoimmune diseases, allergy/immunology, or related therapeutic areas.
• Demonstrated success developing and executing clinical development strategies from early development through registration and lifecycle management.
• Experience leading complex portfolios spanning multiple assets, indications, and development stages.
• Proven capability managing strategic alliances, partnerships, and external collaborations.
• Strong understanding of global regulatory requirements and experience interacting with major health authorities.
• Track record of influencing executive-level decision-making and leading effectively through highly matrixed organizations.
• Exceptional strategic thinking, business acumen, and portfolio management capabilities.
• Outstanding communication, presentation, and stakeholder management skills.
• Ability to operate in a dynamic environment and drive alignment across diverse internal and external stakeholders.
• Demonstrated ability to build, lead, and develop high-performing teams.

Responsibilities

• Oversee Development Leads and multidisciplinary matrix teams responsible for advancing programs across Th2-mediated allergic diseases, rheumatologic diseases, and B-cell-mediated autoimmune diseases.
• Set portfolio priorities across assets, disease areas, mechanisms of action, and indications.
• Manage a team responsible for clinical development strategy and execution from pre-IND through late stage development, ensuring scientific rigor, operational excellence, and regulatory alignment.
• Lead development strategy for key partnered assets, including programs from business development and acquisition activities.
• Serve as the senior Development representative for strategic alliances, governance committees, joint steering committees, and cross-company decision forums.
• Build productive relationships with external collaborators, academic experts, investigators, regulatory agencies, and other stakeholders.
• Collaborate with Research, Commercial, Corporate Development, Regulatory Affairs, Manufacturing, Medical Affairs, Clinical Operations, Biometrics, and other functions to align portfolio objectives and execution.
• Partner with Kite and other strategic internal stakeholders, where applicable, to align development and portfolio strategies.
• Represent Gilead externally in scientific, regulatory, and business forums related to the Inflammation portfolio.
• Serve as a company-wide expert and thought leader in inflammation and autoimmune disease clinical development strategy.
• Ensure development programs are executed in accordance with high scientific, quality, compliance, and ethical standards.
• Attract, develop, mentor, and retain high-performing clinical talent.

Education

M.D. or M.D./Ph.D.

Global clinical development leadership

Experience with inflammation/immunology

Job description

Gilead Sciences Inc. seeks a senior leader to define and execute clinical development strategies in inflammation and autoimmune diseases.

You will guide a multi-asset portfolio from pre-IND through late-stage development, ensuring scientific rigor, regulatory alignment, and strong external partnerships. You will lead matrixed teams, manage governance processes, and partner with internal and external stakeholders to deliver high-impact therapies.